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STATEMENT OF THE PROBLEM
Background
• Approximately 12 million people are diagnosed with cancer each year.1
• In 2010 the cost of cancer treatment was $125 billion, and it is projected to increase to over $158 
billion by 2020.2
Figure 1
• Chemotherapy is a recent intervention in medicine and the number of chemotherapy drugs continues 
to increase.
• With this increase, there is a need to assess the cost-effectiveness data to help make clinical decisions. 
• Studies containing cost-analysis data of specific chemotherapies include:
• Cost-Benefit Analyses
• Cost-Effective Analyses
• Cost-Utility Analyses
• Cost-Minimization Analyses 
Significance of the Problem 
• There are many studies evaluating costs in regards to chemotherapy treatments. However, there is 
lacking a comprehensive review of the data for clinicians to use to make cost-effective, quality medical 
decisions. 
This systematic review will assess the cost-effectiveness of anticancer medications with a special focus on 
the quality of life of patients undergoing chemotherapy with the intent to form recommendations that 
unite evidence-based literature with clinical practice.
OBJECTIVE
SYNTHESIS OF EVIDENCE
REFERENCES
Study Criteria
PROJECT TIMELINE
• Unexplained heterogeneity or inconsistency of results (including problems with subgroup analyses).
• The design and implementation of available studies suggesting high likelihood of bias.
• Ambiguity of disclosed evidence, including bias, limitations, and threats to validity.
• Imprecision of results, such as wide confidence intervals.
• High probability of publication bias.
LIMITATIONS
• Evaluate new studies or literature and incorporate the data into the clinical reference.
• Periodically reevaluate costs associated with chemotherapy treatments.  
FUTURE DIRECTIONS
Spring 2016
• Organize a grading 
rubric to review 
articles
• Establish and 
conduct initial 
literature search
2016-2017
• Establish a 
literature search 
and acquire final 
articles 
2017-2018
• Develop a clinical 
reference for 
providers
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Table 1
• Articles will be assessed in a categorical fashion according to type of neoplasm.
• Final recommendations will be made at the professional judgments of the researchers based on 
pharmacoeconomic data extracted from studies weighted by preference status.
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1
• Define Research Question and Objectives
• See objective subheading
2
• Define Eligibility Criteria
• See study criteria
3
• Define and Conduct Literature Search
• Using predefined terms in relevant and available databases
4
• Review Abstracts
5
• Review Full Text Articles
• Verification of eligibility based on study criteria
6
• Hand Search Reference List and Grey Literature
7
• Data Abstraction and Quality Rating
• Rating completed with a modified GRADE approach
8
• Data Synthesis
• See synthesis of evidence subheading below
Methodology Outline4
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GRADE Score
Cost Benefit 
Analysis
Cost-Effective 
Analysis
Cost-Utility 
Analysis
Cost-
Minimization
Analysis
A Highest High Moderate Low
B High High Moderate Low
C Moderate Moderate Moderate Low
D Low Low Low Lowest
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Figure 2
Figure 3
PROPOSED METHODS
